Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Does Medical Presence Decrease the Perceived Risk of Substance-Related Harm at Music Festivals? - CORRIGENDUM.

Munn MB, White MS, Hutton A, Turris S, Rabb H, Lund A, Ranse J.

Prehosp Disaster Med. 2019 Aug;34(4):460. doi: 10.1017/S1049023X19004631. No abstract available.

PMID:
31389328
2.

Hybrid lipids, peptides, and lymphocytes: new era in type 1 diabetes research.

Hamad ARA, Sadasivam M, Rabb H.

J Clin Invest. 2019 Aug 5;130:3527-3529. doi: 10.1172/JCI130313. eCollection 2019 Aug 5.

3.

Reparative T lymphocytes in organ injury.

D'Alessio FR, Kurzhagen JT, Rabb H.

J Clin Invest. 2019 Jul 1;129(7):2608-2618. doi: 10.1172/JCI124614. Epub 2019 Jul 1. Review.

4.

A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen.

Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell DR, Lee S, Zhang H, Michels A, Desiderio S, Sadegh-Nasseri S, Rabb H, Gritsch S, Suva ML, Cahan P, Zhou R, Jie C, Donner T, Hamad ARA.

Cell. 2019 May 30;177(6):1583-1599.e16. doi: 10.1016/j.cell.2019.05.007.

PMID:
31150624
5.

Keap1-Nrf2 System Plays an Important Role in Invariant Natural Killer T Cell Development and Homeostasis.

Pyaram K, Kumar A, Kim YH, Noel S, Reddy SP, Rabb H, Chang CH.

Cell Rep. 2019 Apr 16;27(3):699-707.e4. doi: 10.1016/j.celrep.2019.03.052.

6.

Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2.

Sadasivam M, Noel S, Lee SA, Gong J, Allaf ME, Pierorazio P, Rabb H, Hamad ARA.

J Am Soc Nephrol. 2019 Feb;30(2):277-292. doi: 10.1681/ASN.2018080815. Epub 2019 Jan 8.

PMID:
30622155
7.

Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.

Gong J, Noel S, Pluznick JL, Hamad ARA, Rabb H.

Semin Nephrol. 2019 Jan;39(1):107-116. doi: 10.1016/j.semnephrol.2018.10.009. Review.

PMID:
30606403
8.

On the Way Out: An Analysis of Patient Transfers from Four Large-Scale North American Music Festivals Over Two Years.

Turris SA, Callaghan CW, Rabb H, Munn MB, Lund A.

Prehosp Disaster Med. 2018 Dec 27:1-10. doi: 10.1017/S1049023X18001188. [Epub ahead of print]

PMID:
30587263
9.

Improving the Supply and Quality of Deceased-Donor Organs for Transplantation.

Tullius SG, Rabb H.

N Engl J Med. 2018 Aug 16;379(7):693-694. doi: 10.1056/NEJMc1808003. No abstract available.

PMID:
30110594
10.

Hurt on the Hill: A Longitudinal Analysis of Obstacle Course Racing Injuries.

Rabb H, Coleby J.

Orthop J Sports Med. 2018 Jun 20;6(6):2325967118779854. doi: 10.1177/2325967118779854. eCollection 2018 Jun.

11.

The Microbiome and Acute Kidney Injury.

Rabb H, Pluznick J, Noel S.

Nephron. 2018;140(2):120-123. doi: 10.1159/000490392. Epub 2018 Jun 29. Review.

12.

Distant Organ Dysfunction in Acute Kidney Injury: A Review.

Lee SA, Cozzi M, Bush EL, Rabb H.

Am J Kidney Dis. 2018 Dec;72(6):846-856. doi: 10.1053/j.ajkd.2018.03.028. Epub 2018 Jun 14. Review.

PMID:
29866457
13.

Characterization of kidney CD45intCD11bintF4/80+MHCII+CX3CR1+Ly6C- "intermediate mononuclear phagocytic cells".

Lee SA, Noel S, Sadasivam M, Allaf ME, Pierorazio PM, Hamad ARA, Rabb H.

PLoS One. 2018 Jun 1;13(6):e0198608. doi: 10.1371/journal.pone.0198608. eCollection 2018. Erratum in: PLoS One. 2018 Jun 27;13(6):e0200056.

14.

Improving the Supply and Quality of Deceased-Donor Organs for Transplantation.

Tullius SG, Rabb H.

N Engl J Med. 2018 May 17;378(20):1920-1929. doi: 10.1056/NEJMra1507080. No abstract available.

PMID:
29768153
15.

Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients.

Boulware LE, Ephraim PL, Ameling J, Lewis-Boyer L, Rabb H, Greer RC, Crews DC, Jaar BG, Auguste P, Purnell TS, Lamprea-Monteleagre JA, Olufade T, Gimenez L, Cook C, Campbell T, Woodall A, Ramamurthi H, Davenport CA, Choudhury KR, Weir MR, Hanes DS, Wang NY, Vilme H, Powe NR.

BMC Nephrol. 2018 May 3;19(1):107. doi: 10.1186/s12882-018-0901-x.

16.

KEAP1 Editing Using CRISPR/Cas9 for Therapeutic NRF2 Activation in Primary Human T Lymphocytes.

Noel S, Lee SA, Sadasivam M, Hamad ARA, Rabb H.

J Immunol. 2018 Mar 1;200(5):1929-1936. doi: 10.4049/jimmunol.1700812. Epub 2018 Jan 19.

17.

Role of Immune Cells in Acute Kidney Injury and Repair.

Lee SA, Noel S, Sadasivam M, Hamad ARA, Rabb H.

Nephron. 2017;137(4):282-286. doi: 10.1159/000477181. Epub 2017 Jun 10. Review.

18.

Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection.

Alachkar H, Mutonga M, Kato T, Kalluri S, Kakuta Y, Uemura M, Imamura R, Nonomura N, Vujjini V, Alasfar S, Rabb H, Nakamura Y, Alachkar N.

BMC Nephrol. 2016 Nov 21;17(1):181.

19.

Nrf2-AKT interactions regulate heme oxygenase 1 expression in kidney epithelia during hypoxia and hypoxia-reoxygenation.

Potteti HR, Tamatam CR, Marreddy R, Reddy NM, Noel S, Rabb H, Reddy SP.

Am J Physiol Renal Physiol. 2016 Nov 1;311(5):F1025-F1034. doi: 10.1152/ajprenal.00362.2016. Epub 2016 Aug 31.

20.

Hospital discharge communications during care transitions for patients with acute kidney injury: a cross-sectional study.

Greer RC, Liu Y, Crews DC, Jaar BG, Rabb H, Boulware LE.

BMC Health Serv Res. 2016 Aug 30;16:449. doi: 10.1186/s12913-016-1697-7.

21.

Kidney epithelium specific deletion of kelch-like ECH-associated protein 1 (Keap1) causes hydronephrosis in mice.

Noel S, Arend LJ, Bandapalle S, Reddy SP, Rabb H.

BMC Nephrol. 2016 Aug 2;17(1):110. doi: 10.1186/s12882-016-0310-y.

22.

Abnormalities in biomarkers of mineral and bone metabolism in kidney donors.

Kasiske BL, Kumar R, Kimmel PL, Pesavento TE, Kalil RS, Kraus ES, Rabb H, Posselt AM, Anderson-Haag TL, Steffes MW, Israni AK, Snyder JJ, Singh RJ, Weir MR.

Kidney Int. 2016 Oct;90(4):861-8. doi: 10.1016/j.kint.2016.05.012. Epub 2016 Jun 28.

23.

Sex and the single transplanted kidney.

Noel S, Desai NM, Hamad AR, Rabb H.

J Clin Invest. 2016 May 2;126(5):1643-5. doi: 10.1172/JCI87428. Epub 2016 Apr 18.

24.

Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets.

Doi K, Rabb H.

Kidney Int. 2016 Mar;89(3):555-64. doi: 10.1016/j.kint.2015.11.019. Epub 2016 Jan 16. Review.

PMID:
26880452
25.

Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.

Noel S, Hamad AR, Rabb H.

Kidney Int. 2015 Dec;88(6):1217-1218. doi: 10.1038/ki.2015.328.

26.

Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps.

Rabb H, Griffin MD, McKay DB, Swaminathan S, Pickkers P, Rosner MH, Kellum JA, Ronco C; Acute Dialysis Quality Initiative Consensus XIII Work Group.

J Am Soc Nephrol. 2016 Feb;27(2):371-9. doi: 10.1681/ASN.2015030261. Epub 2015 Nov 11. Review.

27.

The TALKS study to improve communication, logistical, and financial barriers to live donor kidney transplantation in African Americans: protocol of a randomized clinical trial.

Strigo TS, Ephraim PL, Pounds I, Hill-Briggs F, Darrell L, Ellis M, Sudan D, Rabb H, Segev D, Wang NY, Kaiser M, Falkovic M, Lebov JF, Boulware LE.

BMC Nephrol. 2015 Oct 9;16:160. doi: 10.1186/s12882-015-0153-y.

28.

Double-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human Kidney.

Martina MN, Noel S, Saxena A, Bandapalle S, Majithia R, Jie C, Arend LJ, Allaf ME, Rabb H, Hamad AR.

J Am Soc Nephrol. 2016 Apr;27(4):1113-23. doi: 10.1681/ASN.2014121214. Epub 2015 Aug 27.

29.

Syndecan-1 identifies and controls the frequency of IL-17-producing naïve natural killer T (NKT17) cells in mice.

Dai H, Rahman A, Saxena A, Jaiswal AK, Mohamood A, Ramirez L, Noel S, Rabb H, Jie C, Hamad AR.

Eur J Immunol. 2015 Nov;45(11):3045-51. doi: 10.1002/eji.201545532. Epub 2015 Sep 10.

30.

T Lymphocyte-Specific Activation of Nrf2 Protects from AKI.

Noel S, Martina MN, Bandapalle S, Racusen LC, Potteti HR, Hamad AR, Reddy SP, Rabb H.

J Am Soc Nephrol. 2015 Dec;26(12):2989-3000. doi: 10.1681/ASN.2014100978. Epub 2015 Aug 20.

31.

A prospective controlled study of living kidney donors: three-year follow-up.

Kasiske BL, Anderson-Haag T, Israni AK, Kalil RS, Kimmel PL, Kraus ES, Kumar R, Posselt AA, Pesavento TE, Rabb H, Steffes MW, Snyder JJ, Weir MR.

Am J Kidney Dis. 2015 Jul;66(1):114-24. doi: 10.1053/j.ajkd.2015.01.019. Epub 2015 Mar 17.

32.

Double negative (DN) αβ T cells: misperception and overdue recognition.

Martina MN, Noel S, Saxena A, Rabb H, Hamad AR.

Immunol Cell Biol. 2015 Mar;93(3):305-10. doi: 10.1038/icb.2014.99. Epub 2014 Nov 25. Review.

33.

Intestinal microbiota-kidney cross talk in acute kidney injury and chronic kidney disease.

Noel S, Martina-Lingua MN, Bandapalle S, Pluznick J, Hamad AR, Peterson DA, Rabb H.

Nephron Clin Pract. 2014;127(1-4):139-43. doi: 10.1159/000363209. Epub 2014 Sep 24. Review.

34.

T lymphocytes and acute kidney injury: update.

Martina MN, Noel S, Bandapalle S, Hamad AR, Rabb H.

Nephron Clin Pract. 2014;127(1-4):51-5. doi: 10.1159/000363719. Epub 2014 Sep 24. Review.

35.

Immune cells in experimental acute kidney injury.

Jang HR, Rabb H.

Nat Rev Nephrol. 2015 Feb;11(2):88-101. doi: 10.1038/nrneph.2014.180. Epub 2014 Oct 21. Review.

PMID:
25331787
36.

CD169+ macrophages: regulators of neutrophil trafficking to injured kidneys.

Jang HS, Rabb H, Padanilam BJ.

J Am Soc Nephrol. 2015 Apr;26(4):769-71. doi: 10.1681/ASN.2014090848. Epub 2014 Sep 29. No abstract available.

37.

Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.

Gupta G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, Kraus E, Rabb H, Zachary AA, Montgomery RA, Alachkar N.

Transplantation. 2014 Jun 27;97(12):1240-6. doi: 10.1097/01.TP.0000442503.85766.91.

PMID:
24937198
38.

Isolation of double negative αβ T cells from the kidney.

Martina MN, Bandapalle S, Rabb H, Hamad AR.

J Vis Exp. 2014 May 16;(87). doi: 10.3791/51192.

39.

Variation in structure and delivery of care between kidney transplant centers in the United States.

Israni A, Dean CE, Salkowski N, Li S, Ratner LE, Rabb H, Powe NR, Kim SJ.

Transplantation. 2014 Sep 15;98(5):520-8. doi: 10.1097/TP.0000000000000094.

40.

HuR and other turnover- and translation-regulatory RNA-binding proteins: implications for the kidney.

Pullmann R Jr, Rabb H.

Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F569-76. doi: 10.1152/ajprenal.00270.2013. Epub 2014 Jan 15. Review.

41.

Meta-analysis of molecular response of kidney to ischemia reperfusion injury for the identification of new candidate genes.

Grigoryev DN, Cheranova DI, Heruth DP, Huang P, Zhang LQ, Rabb H, Ye SQ.

BMC Nephrol. 2013 Oct 24;14:231. doi: 10.1186/1471-2369-14-231.

42.

The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice.

Liu M, Reddy NM, Higbee EM, Potteti HR, Noel S, Racusen L, Kensler TW, Sporn MB, Reddy SP, Rabb H.

Kidney Int. 2014 Jan;85(1):134-41. doi: 10.1038/ki.2013.357. Epub 2013 Oct 2.

43.

Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.

Alachkar N, Wei C, Arend LJ, Jackson AM, Racusen LC, Fornoni A, Burke G, Rabb H, Kakkad K, Reiser J, Estrella MM.

Transplantation. 2013 Oct 15;96(7):649-56. doi: 10.1097/TP.0b013e31829eda4f.

44.

Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review.

Purnell TS, Auguste P, Crews DC, Lamprea-Montealegre J, Olufade T, Greer R, Ephraim P, Sheu J, Kostecki D, Powe NR, Rabb H, Jaar B, Boulware LE.

Am J Kidney Dis. 2013 Nov;62(5):953-73. doi: 10.1053/j.ajkd.2013.03.022. Epub 2013 May 29. Review.

45.

Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C, McCullough PA, Kellum JA.

Contrib Nephrol. 2013;182:174-94. doi: 10.1159/000349970. Epub 2013 May 13.

46.

Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

McCullough PA, Kellum JA, Haase M, Müller C, Damman K, Murray PT, Cruz D, House AA, Schmidt-Ott KM, Vescovo G, Bagshaw SM, Hoste EA, Briguori C, Braam B, Chawla LS, Costanzo MR, Tumlin JA, Herzog CA, Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C.

Contrib Nephrol. 2013;182:82-98. doi: 10.1159/000349966. Epub 2013 May 13.

PMID:
23689657
47.

Adiponectin: an enlarging role in acute kidney injury.

Oh J, Rabb H.

Kidney Int. 2013 Apr;83(4):546-8. doi: 10.1038/ki.2012.479.

48.

A prospective controlled study of kidney donors: baseline and 6-month follow-up.

Kasiske BL, Anderson-Haag T, Ibrahim HN, Pesavento TE, Weir MR, Nogueira JM, Cosio FG, Kraus ES, Rabb HH, Kalil RS, Posselt AA, Kimmel PL, Steffes MW.

Am J Kidney Dis. 2013 Sep;62(3):577-86. doi: 10.1053/j.ajkd.2013.01.027. Epub 2013 Mar 22.

49.

Selecting renal replacement therapies: what do African American and non-African American patients and their families think others should know? A mixed methods study.

DePasquale N, Ephraim PL, Ameling J, Lewis-Boyér L, Crews DC, Greer RC, Rabb H, Powe NR, Jaar BG, Gimenez L, Auguste P, Jenckes M, Boulware LE.

BMC Nephrol. 2013 Jan 14;14:9. doi: 10.1186/1471-2369-14-9.

50.

Development of a decision aid to inform patients' and families' renal replacement therapy selection decisions.

Ameling JM, Auguste P, Ephraim PL, Lewis-Boyer L, DePasquale N, Greer RC, Crews DC, Powe NR, Rabb H, Boulware LE.

BMC Med Inform Decis Mak. 2012 Dec 1;12:140. doi: 10.1186/1472-6947-12-140.

Supplemental Content

Support Center